Stock price when the opinion was issued
They're the world leader in dental implants. They're rapidly taking market share in the partially and fully tapared implant launches happening in the fall. They can grow revenues significantly and market expansion. Growth in the last quarter was 20%. (0.6% dividend, Analysts' price target: CHF 793.07)